News | September 30, 2023
Advent International announces the completion of the acquision of Suven Pharma
New Board of Directors and management team at Suven Pharma also appointed
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The delegation's visit covered a wide range of topics
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
WINLEVI works differently from any other topical acne treatment
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Subscribe To Our Newsletter & Stay Updated
